News Trending Zone

Author: BY REBECCA ROBBINS - Publish Date: November 27, 2021 at 02:02AM The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.

Author: BY REBECCA ROBBINS - Publish Date: October 5, 2021 at 12:14AM Las píldoras son eficaces y relativamente baratas, pero es poco probable que estén disponibles para todos los enfermos de covid.

Author: BY REBECCA ROBBINS - Publish Date: October 2, 2021 at 12:20AM The pills are effective and relatively cheap, but they are unlikely to be available for everyone with Covid.

Author: BY EMILY ANTHES AND KATIE ROGERS - Publish Date: September 11, 2021 at 01:02AM Pediatric clinical trials, which will help determine the right vaccine dose for children under 12, are still underway, the agency said.

Author: BY ALYSSA LUKPAT AND EMMA GOLDBERG - Publish Date: September 5, 2021 at 03:11AM The drug has spared hundreds of millions of Africans from serious parasites, but clinical trials have repeatedly failed to show that it is effective against Covid. Still, U.S. demand is high.

Author: BY EMILY ANTHES - Publish Date: August 11, 2021 at 11:45PM The trial of the drugs, already approved for malaria, cancer and autoimmune diseases, will involve researchers at more than 600 hospitals in 52 countries.

Author: BY AINA J. KHAN - Publish Date: August 5, 2021 at 12:39AM The nation, which has not been vaccinating young people without underlying conditions, altered its approach after balancing “potential benefits and harms.”

Author: BY SHERYL GAY STOLBERG, SHARON LAFRANIERE AND NOAH WEILAND - Publish Date: July 26, 2021 at 11:30PM It was unclear whether expanding the studies will have any impact on the timing of when vaccines could be authorized for children on an emergency basis.

Author: BY REBECCA ROBBINS AND PAM BELLUCK - Publish Date: July 9, 2021 at 12:54AM The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.

Author: BY APOORVA MANDAVILLI - Publish Date: July 5, 2021 at 01:23AM France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.

Author: BY ED AUGUSTIN - Publish Date: June 23, 2021 at 01:39AM Rather than rely on imports, the Caribbean nation bet on being able to develop and produce its own coronavirus vaccines, the smallest country to do so.

Author: BY APOORVA MANDAVILLI - Publish Date: June 22, 2021 at 01:51AM Los científicos desaconsejan las pruebas de anticuerpos después de la vacunación. Pero para algunas personas, tiene sentido monitorear su nivel de protección. Un análisis adecuado en el momento justo tal vez ayude.

Author: BY APOORVA MANDAVILLI - Publish Date: June 20, 2021 at 10:03PM Scientists generally recommend against antibody testing after vaccination. But for some people, it makes sense.

Author: BY PAM BELLUCK AND REBECCA ROBBINS - Publish Date: June 6, 2021 at 02:00AM If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.

Author: BY DENISE GRADY AND REBECCA ROBBINS - Publish Date: March 16, 2021 at 07:29AM There is no evidence so far of a link between the AstraZeneca shots and a few new cases in Europe of serious illness and deaths. But investigations are underway.

Author: BY NOAH WEILAND AND REBECCA ROBBINS - Publish Date: March 14, 2021 at 02:00PM Decenas de millones de dosis están a la espera de los resultados de los ensayos. Mientras tanto, los países que ya autorizaron esta vacuna ruegan por tenerlas.

Author: BY NOAH WEILAND AND SHARON LAFRANIERE - Publish Date: February 28, 2021 at 06:12AM The authorization of a third Covid-19 vaccine will bring millions more doses within days. But health officials worry that some people will see the vaccine as the inferior choice.

Author: BY GINA KOLATA - Publish Date: February 23, 2021 at 06:38AM Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.

Author: BY KATHERINE J. WU AND REBECCA ROBBINS - Publish Date: January 4, 2021 at 07:26AM Should second doses be delayed? Should most adults receive half-doses? Scientists are pondering ways to get more shots into more arms.

Author: BY EMILY SCHMALL AND SAMEER YASIR - Publish Date: January 3, 2021 at 01:01PM The approvals, which include a shot developed by Bharat Biotech, an Indian pharmaceutical company, begin a vast campaign to inoculate the hard-hit nation’s 1.3 billion people.